| Authors: |
Neal J; Stanford Cancer Institute, Stanford University, Palo Alto, CA., Pavlakis N; Royal North Shore Hospital, University of Sydney, St Leonards, Australia., Kim SW; Asan Medical Centre, University of Ulsan College of Medicine, Seoul, South Korea., Goto Y; National Cancer Center, Tokyo, Japan., Lim SM; Yonsei University College of Medicine, Seoul, Republic of Korea., Mountzios G; Henry Dunant Hospital Center, Athens, Greece., Fountzilas E; Euromedica General Clinic of Thessaloniki, Thessaloniki, Greece., Mochalova A; MEDSI Clinic, Moscow, Russia., Christoph DC; Evang, Kliniken Essen-Mitte, Essen, Germany., Bearz A; CRO Aviano, National Cancer Institute, IRCCS, Aviano, Italy., Quantin X; Montpellier Cancer Institute, Inserm U1194, University of Montpellier, Montpellier, France., Palmero R; Catalan Institute of Oncology, Barcelona, Spain., Antic V; F. Hoffmann-La Roche Ltd, Basel, Switzerland., Chun E; Genentech Inc, South San Francisco, CA., Edubilli TR; Roche Products Limited, Welwyn, United Kingdom., Lin YC; Genentech Inc, South San Francisco, CA., Huseni M; Genentech Inc, South San Francisco, CA., Ballinger M; Genentech Inc, South San Francisco, CA., Graupner V; F. Hoffmann-La Roche Ltd, Basel, Switzerland., Curran D; Exelixis, Alameda, CA., Vervaet P; Exelixis, Alameda, CA., Newsom-Davis T; Chelsea and Westminster Hospital, London, United Kingdom. |
